Evidence map›Paper›PMID 33409622›Full record

Observational studyAnnals of hematology2021

Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program.

Lene Kongsgaard Nielsen, Rikke Faebo Larsen, Lene Jarlbaek, Sören Möller, Eva Jespersen

Open access · greenAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Annals of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Exercise for myeloma patients with bone disease: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lene Kongsgaard NielsenQuality of Life Research Center, Department of Haematology, Odense University Hospital, Kløvervænget 10, 12. floor, 5000, Odense C, Denmark. lene.kongsgaard.nielsen@rsyd.dk.ORCID https://orcid.org/0000-0003-2083-3870
Rikke Faebo LarsenDepartment of Occupational Therapy and Physiotherapy, Zealand University Hospital, Koge, Denmark.
Lene JarlbaekREHPA - The Danish Knowlegde Centre for Rehabilitation and Palliative Care, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Sören MöllerOPEN - Open Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
Eva JespersenREHPA - The Danish Knowlegde Centre for Rehabilitation and Palliative Care, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
University of Southern Denmark · DKOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with multiple myeloma (MM) report high symptom burden and functional disabilities resulting in impaired health-related quality of life (HRQoL). Effective evidence-based rehabilitation guidelines are needed for patients with MM to improve HRQoL. The primary aim of this study was to investigate HRQoL in patients with rehabilitation needs living their everyday life. Patients with MM in remission attended a 12-week multidisciplinary rehabilitation program including a 5-day residential course, home-based exercise and a 2-day follow-up course. The patients were referred by the treating haematologist and completed a booklet of validated HRQoL questionnaires at baseline and before arriving for the 2-day follow-up course. The proportion of participants with moderate to severe symptoms and functional problems were assessed at the two time points and multivariate logistic regression was used to investigate explaining factors of impaired HRQoL at baseline. Ninety-two patients participated with a follow-up compliance rate of 90%. Median age was 67 years and median time since diagnosis was 26 months (ranged 5 months to 15.6 years). The most frequently reported symptoms were global quality of life, role functioning, fatigue, pain, peripheral neuropathy and physical functioning. Pain and fatigue were both highly coherent with impairment in physical functioning and those two symptoms explained most HRQoL impairments. Overall, the participants reported no change in HRQoL after the 12-week rehabilitation program. The study supports the need for an evidence-based guideline for rehabilitation and palliative care to patients with MM in remission living their everyday life.

Indexed as

Quality of LifeAdultAgedAged, 80 and overExerciseFatigueFemaleHealth StatusHumansMaleMiddle AgedMultiple MyelomaSurveys and QuestionnairesHealth-related quality of lifeMultiple myelomaRehabilitation and patient-reported outcomes

Identifiers

PMID33409622
OpenAlexW3120637621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.